ELEVANCE HEALTH, INC. Payments to Acquire Available-for-sale Securities, Equity
ELEVANCE HEALTH, INC. (ELV) reported Payments to Acquire Available-for-sale Securities, Equity of $5.42 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity · last filed 2018-02-21
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2017-12-31 was $4.93B, a 1556.04% increase year-over-year.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2017-09-30 was -$24.70M, a 116.92% decline year-over-year.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2017-06-30 was $139.00M, a 51.26% decline year-over-year.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for the quarter ending 2017-03-31 was $367.00M, a 50.88% decline year-over-year.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for fiscal 2017 was $5.42B, a 266.88% increase from fiscal 2016.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for fiscal 2016 was $1.48B, a 5.45% decline from fiscal 2015.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for fiscal 2015 was $1.56B, a 71.21% increase from fiscal 2014.
- ELEVANCE HEALTH, INC. payments to acquire available-for-sale securities, equity for fiscal 2014 was $912.00M, a 11.18% increase from fiscal 2013.
| Period end | Payments to Acquire Available-for-sale Securities, Equity 3 month | Payments to Acquire Available-for-sale Securities, Equity 3 month as first filed | Payments to Acquire Available-for-sale Securities, Equity 6 month | Payments to Acquire Available-for-sale Securities, Equity 9 month | Payments to Acquire Available-for-sale Securities, Equity 9 month as first filed | Payments to Acquire Available-for-sale Securities, Equity 12 month | Payments to Acquire Available-for-sale Securities, Equity 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $4.93B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $4.91B derived: sum of 2 quarters · filed 2018-02-21 | $5.05B derived: sum of 3 quarters · filed 2018-02-21 | $5.42B 10-K · filed 2018-02-21 | |||
| 2017-09-30 | -$24.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $114.30M derived: sum of 2 quarters · filed 2017-10-25 | $481.30M 10-Q · filed 2017-10-25 | $779.30M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2017-06-30 | $139.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $506.00M 10-Q · filed 2017-07-26 | $804.00M derived: sum of 3 quarters · filed 2018-02-21 | $950.00M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2017-03-31 | $367.00M 10-Q · filed 2017-04-26 | $665.00M derived: sum of 2 quarters · filed 2018-02-21 | $811.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.10B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-12-31 | $298.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $444.00M derived: sum of 2 quarters · filed 2018-02-21 | $729.20M derived: sum of 3 quarters · filed 2018-02-21 | $1.48B 10-K · filed 2018-02-21 | |||
| 2016-09-30 | $146.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $431.20M derived: sum of 2 quarters · filed 2017-10-25 | $1.18B 10-Q · filed 2017-10-25 | $1.27B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-06-30 | $285.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $1.03B 10-Q · filed 2017-07-26 | $1.13B derived: sum of 3 quarters · filed 2018-02-21 | $1.20B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $747.10M 10-Q · filed 2017-04-26 | $841.60M derived: sum of 2 quarters · filed 2018-02-21 | $919.00M derived: sum of 3 quarters · filed 2018-02-21 | $1.26B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | $94.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $171.90M derived: sum of 2 quarters · filed 2018-02-21 | $509.90M derived: sum of 3 quarters · filed 2018-02-21 | $1.56B 10-K · filed 2018-02-21 | |||
| 2015-09-30 | $77.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $415.40M derived: sum of 2 quarters · filed 2016-11-02 | $1.47B 10-Q · filed 2016-11-02 | $1.85B derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $338.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.39B 10-Q · filed 2016-07-27 | $1.77B derived: sum of 3 quarters · filed 2017-02-22 | $1.94B derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $1.05B 10-Q · filed 2016-04-27 | $1.43B derived: sum of 2 quarters · filed 2017-02-22 | $1.60B derived: sum of 3 quarters · filed 2017-02-22 | $1.73B derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $381.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $552.70M derived: sum of 2 quarters · filed 2017-02-22 | $683.40M derived: sum of 3 quarters · filed 2017-02-22 | $912.00M 10-K · filed 2017-02-22 | |||
| 2014-09-30 | $170.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $301.60M derived: sum of 2 quarters · filed 2015-10-28 | $530.20M 10-Q · filed 2015-10-28 | $885.90M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $130.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $359.30M 10-Q · filed 2015-07-29 | $715.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.11B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $228.60M 10-Q · filed 2015-04-29 | $584.30M derived: sum of 2 quarters · filed 2016-02-19 | $978.90M derived: sum of 3 quarters · filed 2016-02-19 | $1.02B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $355.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $750.30M derived: sum of 2 quarters · filed 2016-02-19 | $791.10M derived: sum of 3 quarters · filed 2016-02-19 | $820.30M 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $394.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $435.40M derived: sum of 2 quarters · filed 2014-10-29 | $464.60M 10-Q · filed 2014-10-29 | $574.40M 10-Q · filed 2013-10-23 | $452.30M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $40.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $150.60M 10-Q · filed 2013-07-24 | $57.70M derived: sum of 3 quarters · filed 2015-02-24 | $116.20M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $29.20M 10-Q · filed 2014-04-30 | $109.80M 10-Q · filed 2013-04-24 | $16.90M derived: sum of 2 quarters · filed 2015-02-24 | $75.40M derived: sum of 3 quarters · filed 2015-02-24 | $161.60M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | -$12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $46.20M derived: sum of 2 quarters · filed 2015-02-24 | $132.40M derived: sum of 3 quarters · filed 2015-02-24 | $232.80M 10-K · filed 2015-02-24 | $292.60M 10-K · filed 2013-02-22 | ||
| 2012-09-30 | $58.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $144.70M derived: sum of 2 quarters · filed 2013-10-23 | $245.10M 10-Q · filed 2013-10-23 | $285.10M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-06-30 | $86.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-24 | $186.60M 10-Q · filed 2013-07-24 | $226.60M derived: sum of 3 quarters · filed 2014-02-20 | $250.70M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-03-31 | $100.40M 10-Q · filed 2013-04-24 | $140.40M derived: sum of 2 quarters · filed 2014-02-20 | $164.50M derived: sum of 3 quarters · filed 2014-02-20 | $225.60M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $64.10M derived: sum of 2 quarters · filed 2014-02-20 | $125.20M derived: sum of 3 quarters · filed 2014-02-20 | $259.00M 10-K · filed 2014-02-20 | $355.60M 10-K · filed 2012-02-22 | ||
| 2011-09-30 | $24.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $85.20M derived: sum of 2 quarters · filed 2012-11-07 | $219.00M 10-Q · filed 2012-11-07 | $378.00M derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2011-06-30 | $61.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $194.90M 10-Q · filed 2012-07-25 | $353.90M derived: sum of 3 quarters · filed 2013-02-22 | $422.90M derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2011-03-31 | $133.80M 10-Q · filed 2012-04-25 | $292.80M derived: sum of 2 quarters · filed 2013-02-22 | $361.80M derived: sum of 3 quarters · filed 2013-02-22 | $447.30M derived: sum of 4 quarters · filed 2013-02-22 | |||
| 2010-12-31 | $159.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $228.00M derived: sum of 2 quarters · filed 2013-02-22 | $313.50M derived: sum of 3 quarters · filed 2013-02-22 | $350.90M 10-K · filed 2013-02-22 | |||
| 2010-09-30 | $69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26 | $154.50M derived: sum of 2 quarters · filed 2011-10-26 | $191.90M 10-Q · filed 2011-10-26 | $315.80M derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2010-06-30 | $85.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $122.90M 10-Q · filed 2011-07-27 | $246.80M derived: sum of 3 quarters · filed 2012-02-22 | $281.50M derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2010-03-31 | $37.40M 10-Q · filed 2011-04-27 | $161.30M derived: sum of 2 quarters · filed 2012-02-22 | $196.00M derived: sum of 3 quarters · filed 2012-02-22 | $325.00M derived: sum of 4 quarters · filed 2012-02-22 | |||
| 2009-12-31 | $123.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $158.60M derived: sum of 2 quarters · filed 2012-02-22 | $287.60M derived: sum of 3 quarters · filed 2012-02-22 | $318.90M 10-K · filed 2012-02-22 | |||
| 2009-09-30 | $34.70M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $163.70M derived: sum of 2 quarters · filed 2010-11-03 | $195.00M 10-Q · filed 2010-11-03 | $284.70M derived: sum of 4 quarters · filed 2011-02-17 | |||
| 2009-06-30 | $129.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-03 | $160.30M 10-Q/A · filed 2010-08-03 | $250.00M derived: sum of 3 quarters · filed 2011-02-17 | $438.00M derived: sum of 4 quarters · filed 2011-02-17 | |||
| 2009-03-31 | $31.30M 10-Q · filed 2010-04-28 | $121.00M derived: sum of 2 quarters · filed 2011-02-17 | $309.00M derived: sum of 3 quarters · filed 2011-02-17 | ||||
| 2008-12-31 | $89.70M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $277.70M derived: sum of 2 quarters · filed 2011-02-17 | $1.33B 10-K · filed 2011-02-17 | ||||
| 2008-09-30 | $188.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-28 | $1.24B 10-Q · filed 2009-10-28 | |||||
| 2008-06-30 | $1.05B 10-Q · filed 2009-07-29 | ||||||
| 2007-12-31 | $1.39B 10-K · filed 2010-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |